Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI™ (milsaperidone) tablets, a first line therapy for the acute treatment ...
thesun.ng on MSN
Basic education in danger
•Death, retirements deplete number of teachers across states•State govts battle to fill gaps as teachers lament shortage of manpower •Some states yet to recruit teachers in 16 years By Okey Sampson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results